Trial Profile
Randomized Double-Blinded Placebo-Controlled Study of Intravenous Immunoglobulin in Mild Cognitive Impairment Due to Alzheimer Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2013
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.
- 05 Mar 2013 New trial record